1 | Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. (Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T) JAMA Ophthalmol 2022 Nov 01;140(11):1085-1094 8 Citations |
1 | The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia. (Guinn D, Lehman A, Fabian C, Yu L, Maddocks K, Andritsos LA, Jones JA, Flynn JM, Jaglowski SM, Woyach JA, Byrd JC, Johnson AJ) Cancer Med 2017 Apr;6(4):778-787 13 Citations |
1 | Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. (Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, Evans DB, Semenza GL, Ellis LM) Am J Pathol 2003 Sep;163(3):1001-11 146 Citations |
2 | Reactive oxygen species are critical mediators of coronary collateral development in a canine model. (Gu W, Weihrauch D, Tanaka K, Tessmer JP, Pagel PS, Kersten JR, Chilian WM, Warltier DC) Am J Physiol Heart Circ Physiol 2003 Oct;285(4):H1582-9 48 Citations |
1 | Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. (Matsunaga T, Warltier DC, Tessmer J, Weihrauch D, Simons M, Chilian WM) Am J Physiol Heart Circ Physiol 2003 Jul;285(1):H352-8 91 Citations |
1 | Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. (Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S, Silverstein RL, Rafii S, Mesri EA) Cancer Cell 2003 Feb;3(2):131-43 211 Citations |
1 | Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis. (Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ) Oncogene 2003 Mar 06;22(9):1365-70 152 Citations |
1 | Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. (Thomas JP, Arzoomanian RZ, Alberti D, Marnocha R, Lee F, Friedl A, Tutsch K, Dresen A, Geiger P, Pluda J, Fogler W, Schiller JH, Wilding G) J Clin Oncol 2003 Jan 15;21(2):223-31 227 Citations |
1 | Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies. (Cortes J, Albitar M, Thomas D, Giles F, Kurzrock R, Thibault A, Rackoff W, Koller C, O'Brien S, Garcia-Manero G, Talpaz M, Kantarjian H) Blood 2003 Mar 01;101(5):1692-7 215 Citations |
1 | Clinical applications of cardiovascular angiogenesis. (Zimmerman MA, Selzman CH, Raeburn CD, Calkins CM, Barsness K, Harken AH) J Card Surg 2001;16(6):490-7 8 Citations |
1 | Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. (Doll JA, Reiher FK, Crawford SE, Pins MR, Campbell SC, Bouck NP) Prostate 2001 Dec 01;49(4):293-305 120 Citations |
1 | Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. (Amaral SL, Papanek PE, Greene AS) Am J Physiol Heart Circ Physiol 2001 Sep;281(3):H1163-9 135 Citations |
1 | Angiogenesis in a patient with ischemic limb induced by intramuscular injection of vascular endothelial growth factor and fibrin platform. (Kipshidze N, Chekanov V, Chawla P, Shankar LR, Gosset JB, Kumar K, Hammen D, Gordon J, Keelan MH) Tex Heart Inst J 2000;27(2):196-200 24 Citations |
1 | Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. (Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R) Clin Cancer Res 2000 May;6(5):1936-48 425 Citations |
1 | Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. (Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM) Circulation 2000 Dec 19;102(25):3098-103 200 Citations |
1 | Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat. (Dawson DW, Volpert OV, Pearce SF, Schneider AJ, Silverstein RL, Henkin J, Bouck NP) Mol Pharmacol 1999 Feb;55(2):332-8 137 Citations |
1 | Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium. (Weihrauch D, Tessmer J, Warltier DC, Chilian WM) Am J Physiol 1998 Sep;275(3):H969-76 39 Citations |
1 | Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. (Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB) Eur J Cancer 1998 Feb;34(3):337-40 161 Citations |